CA2345710C - Preparation of radiolabelled haloaromatics via polymer-bound intermediates - Google Patents

Preparation of radiolabelled haloaromatics via polymer-bound intermediates Download PDF

Info

Publication number
CA2345710C
CA2345710C CA002345710A CA2345710A CA2345710C CA 2345710 C CA2345710 C CA 2345710C CA 002345710 A CA002345710 A CA 002345710A CA 2345710 A CA2345710 A CA 2345710A CA 2345710 C CA2345710 C CA 2345710C
Authority
CA
Canada
Prior art keywords
formula
compound
polymer
group
insoluble polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002345710A
Other languages
French (fr)
Other versions
CA2345710A1 (en
Inventor
Duncan H. Hunter
Xizhen Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Western Ontario
Original Assignee
University of Western Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Ontario filed Critical University of Western Ontario
Publication of CA2345710A1 publication Critical patent/CA2345710A1/en
Application granted granted Critical
Publication of CA2345710C publication Critical patent/CA2345710C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/30Introducing nitrogen atoms or nitrogen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001Acyclic or carbocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/42Introducing metal atoms or metal-containing groups

Abstract

According to a first aspect of the invention, a process is disclosed for the preparation of radiolabelled haloaromatic compounds. According to a second aspect of the invention, intermediate precursor insoluble polymer compounds used in the preparation of the radiolabelled haloaromatics are disclosed, as well as processes for the preparation of the intermediate precursor insoluble polymer compounds.</SDOA B>

Description

PREPARATION OF RADIOLABELLED HALOAROMATICS VIA POLYMER-BOUND INTERMEDIATES

TECHNICAL FIELD

This invention relates to the preparation of a radiopharmaceutical. In particular, this invention relates to a process for the preparation a radiolabelled haloaromatic, as well as intermediate precursor compounds used in the process.

lo BACKGROUND ART

A number of radiolabelled haloaromatic compounds have found application in nuclear medicine. For example, meta-iodobenzylguanidine ("MIBG"), when radiolabelled with the iodine atom, is used in nuclear medicine as either an imaging agent for diagnosis, or as a therapeutic agent for neural crest tumors such as neuroblastoma. When labelled with the shorter-lived iodine-123, [1231]MIBG provides diagnostic cardiac images as well as images of tumors. The longer-lived [131 I]MIBG is used at much higher radiation and chemical doses for the treatment of tumors.

By far the most common method of producing either [1231]MIBG or [131 I]MIBG
is by a Cu+ catalyzed isotopic exchange process which commences with 1-2 mg of MIBG
2o and the desired amount of radioiodide. Because isotopic exchange is an equilibrium process, the product obtained by this process necessarily contains a significant amount of carrier MIBG. Considerable effort' has been placed towards developing a convenient procedure that proceeds in near quantitative radiochemical yields. However, this method has the drawback of producing [131 I]MIBG of low specific activity resulting in chemical doses of 1-5 mg when therapeutic samples are prepared. Doses of this magnitude carry potential hypertensive side effects.

Accordingly, routes to no-carrier-added ["'I]MIBG have been developed which could reduce the chemical dose of MIBG by about a factor of 100.
Precursors to no-carrier-added [731I]MIBG, such as 3-tributylstannylbenzylamine2, 3-trimethylsilylbenzylguanidinel, and 3-trimethylstannylguanidinium3, have not found widespread application. These compounds have a short shelf life, and must be stored in a freezer shielded from light.

United States Patent No. 5,565,185 discloses a no-carrier-added process of radiolabelling MIBG by halodestannylation. However, the process is disadvantageous in that a number of impurities remain in solution with the radiolabelled MIBG. In particular, toxic tin by-products remain in solution and must be separated before the radiolabelled MIBG is ready for use.

Accordingly, there is a need for a process for no-carrier-added synthesis of radiolabelled haloaromatic compounds, which can be easily and practically separated from possibly toxic impurities.

DISCLOSURE OF INVENTION

It is an object of the invention to provide a process for no-carrier-added synthesis of radiolabelled haloaromatic compounds, where the impurities can be removed by simple filtration, thereby making the process suitable for "kit"
formulation.

It is also an object of the invention to provide intermediate insoluble polymer precursors which have a long shelf life and can be stored at room temperature without special conditions, and to which the uniabelled compounds and side products are bound, thereby facilitating removal of these undesirable impurities by filtration.
According to a first aspect of the present invention, a process of preparing a radiolabelled haioaromatic compound (i) of the formula:

X i R2 is provided, wherein, R= is selected from an alkyl group, an aryl group, a hydrogen atom, a halogen atom, a substituted oxygen atom, a substituted riitrogen atom, a substituted sulfur atom, a carbonyl group, a cyano group, an aminomethyl group, and a guanidinomethyl group. `X is selected from any suitable radiohalide, and is preferably selected from'2'1, "51, and 1311. The process comprises reacting an insoluble polymer compound (li) with a radlohalogen ion in the presence of an oxidant and a preferably organic solvent, where compound (II) has the lo formula:

Ri i Polpmer-S I n 0 Rl R2 wherein, R, is an alkyl group, and is preferably a butyl group. R2 is as described above.

According to a second aspect of the invention, an intermediate insoluble polymer compound is provided. The compound comprises the repeating unit formula:

Rt I
Polymer-S I n R2 Rt wherein, R, Is selected from an alkyl group; and R2 is selected from an alkyl group, an aryl group, a hydrogen atom, a halogen atom, a substituted oxygen atom, a substituted nitrogen atom, a substituted sulfur atom, a carbonyl group, a cyano group, an aminomethyl group, and a guanidinomethyl group.

According to a third aspect of the invention, a process of preparing an intermediate insoluble polymer compound of formula:

C4iiq Polymer- n CAHy is provided. The process comprises reacting the compound of formula:
Ci Sn~
C411~ C4H9 with a 1-(3-bromobenzyt)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine compound of the structural formula:

I ~ CH3 Br N Si Si According to a fourth aspect of the invention, a process is provided for preparing an intermediate insoluble polymer compound of formula:

NH
~4~ ~ ~
Polymer-Sn H2N +
c,x, comprising the steps of:

(a) reacting a first insoluble polymer compound of formula:

ci n Sn C4Hg C4H-9 with a 1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine compound of the structural formula:

I~CH3 Br Si AMENDED SHEET

to produce the compound having the formula:

NH3+

Polymer-Sn (b) reacting a compound having the formula:
M3+

Polymer-Sn with toluene and NCNH2 ta convert the ammonium group to a guanidinium group.

According to a fifth aspect of the invention, a process is provided for preparing a compound of the formula:

N NH
i 'Y +
NHz comprising contacting a compound of the formula:

C~I'q >= NI12 Polymer-Sn H21Y +
c4EIq with iodine in an organic solvent.

According to a sixth aspect of the invention, a process is provided for preparing a compound of the formula:

~ S
~
ni ~ N NH2 'Y +
wherein n is selected from 123, 125, and 131;

the process comprising contacting a compound having the formula:
NH
4~4i9 Nlh Polymer-Sn HZN +
c,H9 with a solution of Na"1 and an oxidizing agent in the presence of a buffering agent; wherein n is as described above.

Further features of the invention will be described or will become apparent in the course of the following detailed description.

BRIEF DESCRIPTION OF THE DRAWINGS

In order that the invention may be more clearly understood, the preferred to embodiment thereof will now be described in detail by way of example, with reference to the accompanying drawings, in which:

Fig. 1A shows the 19Sn MAS NMR spectrum for Polymer 1;

Fig. 1B shows the 19Sn MAS NMR spectrum for Polymer 1 after hydrolysis;
Fig. 1C shows the 19Sn MAS NMR spectrum for Polymer 2;

Fig. 1D shows the 119Sn MAS NMR spectra for Polymer 3 recovered after iodination; and Fig. 2 shows the HPLC analysis of the iodination products of reaction of Polymer 2 with cyanamide at selected reaction times.

2o BEST MODE FOR CARRYING OUT THE INVENTION

The process, according to the present invention, provides for the radiohalogenation of a haloaromatic compound using a polymer-supported pharmaceutical, as follows:
~ X ~
Polymer-Sn I~ b Polymer-Sn-Nu +- *X R2 Ri Rz R2 ineoiub>e polyrrmc by`fxoduet R. R2 irsohbie poiyarr radiopt~iacat wherein:

R, is an alkyl group, and is preferably a butyi group.;

R2 is selected from an alkyl group, an aryl group, a hydrogen atom, a halogen atom, a substituted oxygen atom, a substituted nitrogen atom, a substituted sulfur atom, a carbonyl group, a cyano group, an aminomethyi group, a guanidinomethyl group;

Nu is a nucleophile provided by the solvent or oxidant; and 'X is selected from any suitable radiohalide, such as, for example, 1311 or1231.

Although the preferred embodiment of the present invention refers to lo isotopes of Iodine only, such references are intended by way of example, and are not intended to be limiting. The present invention may be appGed to any suitable radiohalide.

According to a preferred embodiment of the present invention, a process is provided to synthesize no-carrier-added ("`IJMIBG or ('2311MIBG using polymer-supported radiopharmaceutical precursors4. An insoluble polymer is prepared in which the pharmaceutical to be radiohalogenated is bound to the polymer through a tin-aryl bond as illustrated above. Treatment with the radiohalide and an appropriate oxidant results in the release of the radiohalogenated pharmaceutical while unreacted polymer and polymer side-products remain insoluble and easily removed by fiitration.

The polymer above is derived by reaction of the appropriate organolithium 2o with a polymeric chlorostannane. Polymer 1, described in detail below, is used as an intermediate compound to derive the polymers to be used in the radiohalogenation of a haloaromatic compound. Polymer 2 is one such reagent derived from Polymer 1, and Polymer 3 is the preferred polymer-supported 3-benzylguanidinium reagent for the preparation of no-carrier-added [131 I]MIBG or [t2311MIBG. Polymers 2 and 3 are also described in detail below.

Preparation of Poly-3-and -4-( 2-dibutytchtorostannyt ethyl )styrene: Polymer Polymer 1 has the following structural formula:

CI
Sn CA CA
and was prepared by a known procedure5, as shown schematically below.
1) (C4H9)2SnC12 , (C4H9)2SnH2 AIBN, < 30 C , overnight 2) DVB , AIBN , 1-octanol , Sn methylcellulose, H20, reflux , 8 h 1 C4H9 \C4H9 After being run through a short silica column to remove antioxidant, commercial divinylbenzene (36 g, 225 mmol) and di-n-butyidichlorostannane (35 g, 115 mmol) were reacted ovemight under nitrogen with dibutylstannane (27.5 g , 115 mmol) in the presence of AIBN (0.75 g, 4.6 mmol) near or below 30 C. Then divinylbenzene (6.5 g, 40.6 mmol), AIBN (1.25g, 7.6 mmol), 1-octanol (85.5g) and methyl-cellulose (0.63 g) dissolved in water (250 mL) were added to the previously prepared monomer.
This mixture was refluxed for 8 h in a resin kettle under nitrogen with rapid stirring ( 1000 rpm).
After cooling, water was added to the resin kettle and the solution was decanted from the granular polymer particles. Washing with water was continued until the supernatant ran clear. After a similar treatment with acetone (5 x 200 mL), the polymer was filtered with a coarse sintered-glass funnel and washed with methanol (2 x 200 mL), toluene (3 x 200 mL) and THF (3 x 200 mL). After drying ovemight under vacuum at room temperature, 66.5g (73% yield by weight) of white grainy solid was obtained.

The characteristics of Polymer 1 are preferably as follows:

= Solid-state MAS 13C NMR (swollen with CHCI3), S ppm: 14.6 (CH3), 18.6 (Sn-CH2-), 27.7 (-CH2CH2CH,), 28.6 (-CH2CH3), 42 (broad, Ar-CH-, Ar-CH2- and backbone -CH2-), (broad, aryl CH), 144 (broad, Aryl C).

= Solid-state MAS 19Sn NMR (swollen with CHCI3), S ppm.: 148.

= DRIFT spectrum, cm'': 3036, 3060 (aromatic C-H); 2968, 2938, 2879, 2860 (aliphatic C-H); 1604, 1510 (aromatic C=C vibrations), 1486, 1450.2968, 2938, 2879, 2860 (aliphatic C-H); 1604, 1510 (aromatic C=C vibrations), 1486, 1450.

Samples of Polymer 1 were prepared as indicated above. Polymer I was characterized both chemically and spectroscopically. The availability of Sn-Cl bonds was assessed by treatment of Polymer I with KOH in ethanol/THF at room temperature.
Polymer 1 (201 mg) was soaked in 7 mL of absolute ethanol, 3 mL (3 mmol) of 1 M

potassium hydroxide, and 1 mL of tetrahydrofuran for 24 h at room temperature.
The polymer was filtered and washed with 70 % ethanol (5 x 5 mL). The ethanol and THF in the filtrate were removed on rotary evaporator and the residual liquid was transferred into a 50 mL volumetric flask and topped up to the mark with water. Then 20 mL of this solution was diluted to 50 mL Erlenmeyer by addition of 1 M nitric acid. This solution was then titrated for CI- following the Mohr procedure.6 The amount of chloride ion released was found to be 1.7 t 0.1 mmol/g of polymer. If the polymer was composed exclusively of the units indicated in the structure shown for Polymer 1, the maximum amount of chloride released would be 2.5 mmoUg of polymer. However, significant amounts of divinylbenzene had been used when forming the polymer and the yield of material was 32 %.

Polymer I was also investigated by MAS NMR spectroscopy on samples that had been preswollen with chloroform which had the effect of sharpening the signals. The 73C NMR spectrum was consistent with the anticipated structure showing signals for all of the carbons. The signals for the backbone CH and CH2 and phenyl carbons were quite 1o broad and indistinct. However, the CH2-CH2 carbons and the carbons on the butyl chains were readily assigned by analogy with non-polymeric species. The 19Sn NMR
spectrum (Figure 1A) showed but one peak at 148 ppm consistent with species of the general structure R3Sn-CI. This confirmed that all of the tin atoms were bonded to chlorine in spite of the apparent discrepancy in the hydrolysis results mentioned above. This was particularly reassuring since IR spectra invariably gave a broad absorption near 3500 cm-' which was consistent with hydrolysis of the Sn-Cl bond to Sn-OH. The 119Sn NMR spectrum of hydrolysed material (Figure 1 B) was obtained and showed the complete absence of the peak at 148 ppm with a group of peaks appearing at about 90 ppm which confirmed that Polymer 1 has tin bonded exclusively to chlorine and that all of these bonds are available for 2o hydrolysis.

As illustrated in detail below, Polymer 1 was preferably converted in two steps first into Polymer 2 which bears the 3-benzylammonium moiety and then into Polymer 3 functionalised with a 3-benzylguanidinium species.
~ o = - ~ = = = = ~ ^ n o o w = o , , e = = = = = = = - . = = = ~
. = = = = = = e o -= = = o = = = = = = = = =~, = === ===
= = = = = = = = o = =
= = == == == == == ==
Preparation of poiymer-supported 3-benzyiammonium chloride: Polymer 2 Preparation of 1-(3-bromobenzyl)-2.2.5.5-tetramethyl-1,2.5-azadisilolidine:
Compound 4 The conversion of Polymer 1 into Polymer 2 was preceded by the preparation of 1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine. 3-Bromobenzylamine hydrochloride (25.0 g, 112.3mmol) was converted to the free base by neutralization with sodium hydroxide and extraction into methylene chloride. Drying and solvent removal resulted in 20.3 g of a brown liquid which was used as such. To the above 3-bromobenzylamine (20.3 g, 109mmol) , in a round bottom flask equipped with a condenser and under argon atmosphere, was added 150mL of methylene chloride and 30.3mL

lo (217mmol) of triethylamine. To this stirred mixture cooled with an ice-bath was added slowly 109mL (109mmol) of 1 M 1,2-bis(chlorodimethylsilyl)ethane dissolved in methylene chloride. During the addition, considerable precipitate formed. The ice-bath was removed and the mixture was stirred for another 6.5 h at room temperature. The white solid was removed by filtration and washed with methylene chloride (2 x 30mL). The filtrate was evaporated using a rotary evaporator resulting in further precipitate formation. Hexanes (100mL) were added to this mixture. The solid was removed by filtration and washed with . t.
hexanes (2 x 20mL). After hexane removal from the filtrate, a yellowish liquid was obtained which was distilled to yield 29.0 g (82% yield) of light yellowish liquid ( bp. 93-5oC/0.05 mm Hg).
Compound 4 preferably had the following characteristics:

='H NMR spectrumS (acetone-d6 ): S 0 (s, 12H, CH3); 0.79 (s, 4H, Si-CH2-CH2-Si); 4.05(s, 2H, Ar-CH2-N); 7.25 ( t, 1 H, 5-H ), 7.30 ( d, 1 H, 6-H ), 7.38 ( d, 1 H, 4-H
), 7.47 ( s, 1 H, 2-H ).

= 13C NMR spectrum (chloroform-d ): 5 0 (CH3); 8.2 ( Si- CH2- CH2-Si); 45.8 (Ar- CH2-N);
122.4 ( C-3), 126.3 ( C-6), 129.5 (C-5), 129.7 ( C-2),130.9 (C-4), 146.2 (C-1). IR ( neat):
AMENDED SHEET

. ~~ ..
cm-' 3068 (aromatic C-H stretch); 2949, 2903, 2857 ( aliphatic C-H stretch);
1604, 1484 ( aromatic C=C vibrations ); 849 (vs asymmetric (Si-N-Si stretching), 784( pCH3), 678 (võSi-C). ( aromatic C-H bending). MS: M/Z 329, 327, 314, 312, 169, 130, 116, 100, 90, 73, 59, 45. Anal. required for C13H22BrNSiZ, m/e 327.0474; found, m/e 327.0479.

Following the preparation of 1 -(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine, the preparation of Polymer 2 proceeded as follows:
1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisiloiidine cili ~.sisi-I ~
r I CH6 I ~CH3 Ntz Ci4 Br N~Si \ ~ I
NEt3 / CHZCIZ Si RT, 6.5 h J;D~~C^' 1) 1x nBuLi / THF, -78 l ~+
Sn ~
CyHy 2) Polymer 1, -78 o to RT, overnight 3) washed with 0.01 M HCI / EtOH
Polymer 2 To 25.0 g (76.1 mmol) of Compound 4 in a three-neck flask equipped with an argon inlet, a serum cap and a powder addition sidearm containing Polymer 1( 28.6 g ) was added 250 mL of freshly distilled dried tetrahydrofuran. To this flask cooled to -78 C was added slowly 30.5 mL (76.1 mmol) of 2.5 M n-butyllithium. The initially colourless solution turned purple and then brownish at 25 min. Polymer 1 was then tipped into the reaction solution and the mixture was stirred gently in the dry-ice-acetone bath for 7 h. After the temperature was allowed to rise to room temperature over 2 h and then held at room temperature for another 1 h,- methanol (10 mL) was added followed by sufficient 1 M
AMENDED SHEET

hydrogen chloride to give a pH of 4-5. The mixture was stirred overnight and allowed to stand unstirred for 15 min.

After the upper cloudy solution was decanted, 200 mL of methanol was added. Again the cloudy upper layer was decanted and this process was repeated 4 times.
The polymer was filtered through a coarse sintered glass funnel and washed with 50%

methanol/water solution (100 mL), methanol (3 x 100 mL), and 95% ethanol (50 mL). After vacuum drying at room temperature, 30.1 g (84 wt % yield) of a white grainy material was obtained.

The characteristics of Polymer 2 were preferably as follows:

lo = Solid-state MAS 13C NMR spectrum: S 14.6 ( CH3 ), 18.6 ( Sn-CHZ_ ), 27.7 (-CH2CH2CH3), 28.6 (-CH2CH, ), 42 ( broad, Ar-CH-, Ar-CH2- and backbone -CH2_ ), 128 (broad, aryl CH), 144 ( broad, Aryl C) = Solid-state MAS 119Sn NMR spectrum: 8 -43.6 ppm = IR spectrum (KBr): cm'' 3435 (broad, -NH3` stretches); 3027(aromatic C-H
stretch);
2927, 2857 (aliphatic C-H stretches); 1611, 1498 (aromatic C=C vibrations).

Because 3-bromobenzyl amine has reactive NH bonds, the amino group was first protected as an azadisilolidine' and then reacted with one equivalent of n-butyllithium.
Polymer 1 was added to the presumed monolithium species so prepared. Polymer 2 was characterized by13C and "sSn MAS NMR spectroscopy.

The 13C NMR spectrum was consistent with the proposed structure. Again, the signals attributed to the backbone CH and CH2 carbons and the phenyl carbons appeared as broad peaks. The peaks due to the Sn-CH2-CH2 carbon was identifiable as well as the carbons of the n-butyl group. The benzylic carbons were not readily identified.
Perhaps most characteristic was the shift in the Sn-CH2-C,H, carbon signals from 18.6 ppm for Polymer 1 to 10.5 ppm for Polymer 2. Again the IR spectrum gave a broad absorption near 3500 cm-' indicating that considerable hydrolysis accompanied this reaction. However as indicated in Figure 1 C, the 19Sn spectrum showed primarily one peak at -43.6 ppm with a small peak at 90ppm consistent with SnOH and representing about 10 % of the tin signals.
Thus it would seem that all of the Sn-Cl bonds had reacted with the organolithium reagent with a small amount of concurrent hydrolysis.

lodination of Polymer 2 The iodination of Polymer 2 proceeded in accordance with the following reaction:

n jct"~ NH3+ I2 / CH3CN ~
Sn 3 C414' 'C4I4 RT, 16.5 h Polymer 2 3-Iodobenzylammonium To the previously prepared Polymer 2 (100 mg) was added 10 mL of methanol and I mL of 0.2 M iodine in acetonitrile solution. After stirring gently at room temperature for 16.5 h, 1 mL of 1.0 M sodium metabisulphite solution was added. The mixture was transferred into a 100 mL volumetric flask and topped up to 100 mL
with 0.01 M

KH2PO4. An aliquot was filtered through a syringe filter, and the fiitrate was analyzed by HPLC . The retention time of 3-iodobenzylammonium peak was 8.8 min and the amount was determined by comparison to a standard 3-iodobenzylammonium hydrochloride solution (0.4 mM ).

The extent of reaction in forming Polymer 2 and the availability of the 3-benzyl ammonium species in Polymer 2 was probed by reaction with iodine as illustrated above. This was anticipated to yield the 3-iodobenzyl ammonium ion ("MIBA") which was identified and quantified by HPLC. It was found that about 0.95 0.05 mmoi/g of 3-iodobenzyl ammonium ion was released per gram of Polymer 2. Again this was somewhat less that the maximum calculated amount if Polymer 2 had the structure indicated above.
However, 19Sn NMR spectroscopy proved to be of considerable value as shown in Figure 1 D. A comparison of Figure 1 C for Polymer 2 and Figure 1 D for polymer 2 recovered after iodination shows a complete loss of the signal at -43.6 ppm consistent with complete release of the 3-benzyl ammonium group.

Preparation of polymer-supported 3-benzyiguanidinium chloride: Polymer 3 Preferably, the synthesis of Polymer 3 involved treatment of Polymer 2 with a lo large excess of cyanamide to convert the ammonium group into a guanidinium group, as illustrated below.

n NCNHZ n NH3.
So Toluene, 540,25 h / ~ Y+
C.~~ \C't4 C~~ ~N! Nth Polymer 2 Polymer 3 Under an argon atmosphere, 20.0 g of Polymer 2, 15.1 g(360mmol) of cyanamide, 100 pL (0.72mmoi) of triethylamine and 250mL of toluene were added to a flask equipped with a reflux condenser. The mixture was heated for 25 h at 54 C and the hot reaction mixture was filtered through a coarse sintered glass funnel. The polymer was washed with acetonitrile (4 x 100 mL), methanol (4 x 100 mL) and acetonitrile (2 x 100 mL).
After vacuum drying at room temperature overnight, 20.7 g of white grainy material was obtained.

The characteristics of Polymer 3 are preferably as follows:
= IR spectrum (KBr ): cm'' 3340, 3271, 3174 (N-H stretch); 3066, 3027 (aromatic C-H
stretch); 2978, 2929, 2880, 2860 (aliphatic C-H stretch); 1677, 1658 (C=N
stretch);
1521, 1496 (aromatic C=C vibrations); 719 (aromatic C-H bend).

lodination of Polymer 3 The iodination of Polymer 3 proceeded in accordance with the following reaction:

n ~C4 H I 2 / CH3CN H
~ N ~ v ~
~
H9~ n CdH9 ~+ CI" RT,13.5 h Ntk N%
Polymer 3 3-Iodobenzyiguanidinium NIIBG
To 26.4 mg of Polymer 3 suspended in 4 mL of methanol was added 300 NL

of 0.2 M iodine in acetonitrile solution. After stirring for 13.5 h at room temperature, 0.1 mL
of 1 M sodium metabisuiphite solution was added. The mixture was transferred into a 100 mL volumetric flask and topped up to 100 mL with 0.01 M KHzPO4 buffer. After filtering through a syringe filter, the filtrate was analysed by HPLC by comparison to standard 3-iodobenzylammonium chloride solutions (0.4 mM) and 3-iodobenzylguanidinium chlorideref solutions (0.2 mM) which had a retention times of 8.7 min and 15.6 min respectively.

Unreacted ammonium groups resulted in the release of the 3-iodobenzyl ammonium ion while ammonium groups that had reacted with cyanamide would result in the release of the 3-iodobenzyl guanidinium ion, as illustrated above. Thus, at selected time intervals, polymeric material was isolated from the reaction mixture and treated with an excess of iodine. After reduction of the iodine, aliquots were analyzed by HPLC and the 2o results are presented in Figure 3. At 75 C after 1 h, 80 % of the ammonium groups had been converted to guanidinium groups and by 2 h conversion had progressed to 96.2 %. By 5h, there was less than 0.3 % of unreacted ammonium groups.

However, a new peak with a retention time slightly longer than the 3-iodobenzyl guanidinium was observed. This material was identified to be the 3-iodobenzylbiguanidinium ion in two ways. First, an authentic sample of 3-iodobenzylbiguanidinium nitrate was produced8, as described in detail below.
The sample was found to have an identical retention time with the new peak. Secondly, a small sample of the new material was isolated from a reaction that was allowed to run considerably longer and at a higher temperature than those shown in Figure 2. Although not enough material lo could be isolated in a sufficiently pure form to allow a mixed mp., the 13C
NMR spectrum was identical with the authentic sample of 3-iodobenzylbiguanidinium nitrate that had been produced. The guanidinium group reacted further with cyanamide, but at a rate considerably slower than the ammonium group so that the biguanidinium species does not start to appear until very late in the conversion process.

is With this time course in mind, a reasonably large batch of polymer 2 was reacted for 25 h. at 54 C. After the ususal washing, Polymer 3, so produced, was analyzed by iodination to yield 3-iodobenzyi guanidinium at a level of 1.1 0.05 mmol/g of Polymer 3.

Preparation of 3-iodobenzylbiguanidinium nitrate 20 In a 25 mL flask, 3-iodobenzylamine hydrochloride (2.0 g, 7.4 mmol) was combined with 0.62 g (7.4 mmol) of dicyandiamide and an argon atmosphere was introduced. The mixture was melted at 154 C for 30 min and water ( 20 mL ) was added to dissolve the brownish solid. HPLC analysis showed 8 mol % of 3-iodobenzylamine hydrochloride, 17 mol % of MIBG and 75 mol % of 3-iodobenzylbiguanidinium nitrate 25 (excluding dicyandiamide at 9.6 min ) with a retention times of 6.1 min, 11.2 min and 12.7 min respectively. After decolorizing with charcoal, the solution was adjusted to pH-9 with saturated sodium carbonate. The upper aqueous solution was decanted from the oil which was separated. Water (5 mL) was added to the oil followed by 1 M nitric acid to a pH~5. A
lot of bubbles formed during the addition of nitric acid and the mixture turned into a clear solution at pH~5. White crystals formed about 1 minute later.

After 20 min. at room temperature, the crystals were collected by filtration and washed with water (3 x 3 mL). After drying, 1.22 g of white crystals were obtained.
Concentration of the filtrates to about 10 mL yielded 0.23 g more of white crystals. The two batches of crystals were combined and recrystallized using acetonitrile (25 mL) to provide 1o 0.25g of white mushroom shape crystals. HPLC analysis showed 99 mol % of 3-iodobenzylbiguanidinium nitrate, 1 mol % of MIBG and dicyandiamide. The 0.25 g of crystals were recrystallized again from 6 mL of acetonitrile to yield 99.3 mg ( 4 %
yield) of white mushroom shape crystals of mp 133.5-134.5 C.

The characteristics of the3-iodobenzylbiguanidinium nitrate were preferably as follows:

='H NMR spectrum (methanol-d4): S 4.34 ( d, 2H, CHZ ), 7.05 (t, 1 H, 5-H ), 7.28 ( d, 1 H, 6-H), 7.56 ( d, 1 H, 4-H ), 7.63 ( s, 1 H, 2-H ).

= 13C NMR spectrum (methanol-d4): S 45.5 ( CH2), 95.3 ( C-3), 127.9 (C-6), 131.5 ( C-5), 137.4 ( C-2), 137.5 (C-4), 142.4 ( C-2), 160.3 (middle C=N), 162.1 (terminal C=N).

= FT-IR spectrum (KBr): cm-' 3506, 3467, 3428, 3330, 3301, 3213 (N-H stretch);
2968.1, 2938.9 (aliphatic C-H stretch); 2440 (-NH2+ stretch); 1658, 1638 (C=N
stretch); 1555 (asymmetric N03- stretch); 1428.0, 1394 (symmetric N03- stretches); 782 (aromatic C-H bend).

= UV spectrum: 5,,,,=232nm , e,õ,,=2.49 x 104. Anal. calc'd for C9H131N6O3: C, 28.44;
H, 3.45; N, 22.11; I, 33.38. Found: C, 28.61; H, 3.44; N, 22.07; I, 33.19.
Radiolodination of Polymer 3 - -Following the successful completion of the iodination of Polymer 3, the radioiodination of Polymer 3 using sodium [1311]iodide, proceeded in accordance with the following reaction:

1) Na1"I, H=O=, HOAc n MeOH, 0.1 M lOi=PO4 ~C'w I \ H 2 h, RT ~ H
Sn ~ N ~ 131I \ I I
N ~
`C+~ N% 2) 0.1 M Na2S=OS +
N%
~n~G
Polytner 3 131 Into a 2 mL vial was placed 0.5 mg of Polymer 3, 300 pL of methanol, 100}rI
of 0.1 M potassium dihydrogen orthophosphate, 45.5 MBq of a Na13'I solution and a 100 pL
aliquot of a solution prepared from 2 mL of acetic acid and 2 mL of 50 %
hydrogen peroxide solution diluted to 50 mL with water. The mixture was occasionally shaken for 2 h at room temperature and then 200 NL of 0.1 M sodium metabisulphite was added to the reaction mixture.

After filtration through a syringe filter, the filtrate was analyzed by HPLC.
The UV detector trace showed a large peak at the solvent front and several smaller peaks well before MIBG peak. The corresponding radioactivity detector trace showed two peaks at 1.9 and 15.6 min which were confirmed by coinjection to be 1311 -( 2.4 % ) and ["'I]MIBG
(97.6%) respectively.

An aliquot of the reaction mixture , 25.4 MBq, was passed through a Sep-PakTM' cartridge and washed with 5 mL of water. Radioactivity was found in the washes, 1.0 MBq, and on the cartridge, 24.4 MBq. Washing of the cartridge with 1.3 mL of 42% ethanol, 2o released 20.0 MBq of radioactivity into the washes. A wash with 1 mL of methanol released a further 3.1 MBq of [131 I]MIBG for a total of 23.1 MBq (95 %). The washes were analyzed by HPLC. The trace from the UV detector showed two small peaks at the solvent front and a peak at 15.6 min which, by coinjection, was confirmed to be MIBG. The corresponding radioactivity trace showed a single peak at 15.6 min.

The success of the radioiodination was assessed by HPLC using both an UV
detector and a y-ray detector. The oxidant, H2O2/HOAc, or its by-products are readily separable from any [131I]MIBG produced, and results of this oxidizing system are presented in Table 1. Labelling reactions were run at room temperature on about one or two grains of Polymer 3 in a mixture of methanol and 0.1 M KH2PO4 using Na13'I. Under these conditions io after filtration, essentially all of the radioactivity was found in solution either as 131I- or as [131 I]M1BG as evidenced by their HPLC retention times using a radioactivity detector. Table 1 shows the effect on the radiochemical yield of [13'I]MIBG of increasing the concentration of H202 and acetic acid at various reaction times. As the first column indicates, the exclusion of acetic acid from the reaction mixture led to low yields and apparently slow reactions. The third column indicates a general increase in yield with reaction time. At two hour reaction times, increasing concentrations of H202 and acetic acid led to increased yields which approached near quantitative conversion. It was these conditions that were chosen for preparation of [137I]MIBG, as illustrated.

Table 1. Radiochemical yield of ['3'IJMIBG from treatment of Polymer 3 with Na and H202/HOAc as oxidant as a function of reaction time and oxidant concentration Reactian'time [H202], mM / [HOAc], mM
tmin) 5010 20/24 24 37 / 42 501,57 60168 ' Reactions were run at room temperature in a mixture of methanol and 0.1 M
KH2PO4.
Purification of the product from the radiolabelling reaction involved two steps.
The first was simple filtration through a syringe tip filter. An HPLC analysis of this product using a UV detector showed a large peak at the solvent front and several minor peaks. The radioactivity detector showed two peaks corresponding tot311- at about 2 % and the other to [131 I]MIBG at 98 %. The second step in the purification involved selective absorption and desorption of the ("'I]MIBG onto a C18 Sep-PakT"" cartridge. When the primarily aqueous solution from the filtration step was passed through the C18 Sep-PakT""
cartridge, essentially all of the radioactivity was absorbed onto the cartridge with the small amount of iodide passing through. When the cartridge was washed with ethanol/water, 82 % of the radioactivity was released. A further 10 % was released when methanol was used as eluant.

An HPLC analysis of these solutions, using an UV detector, showed two small peaks near the solvent front and a small peak at the retention time of MIBG. The area of this peak was rather too small to allow a reliable calculation of the specific activity of the ["'I]MIBG. The corresponding radioactivity trace showed but one peak at the retention time of MIBG. Thus following this procedure, the no-carrier-added [13'I]MIBG was produced in about 92 % radiochemical yield with a specific activity of >_500 Ci/mmol..

['Z31]MIBG was produced using IodobeadsTM as the oxidant, which resulted in a radiochemical yield of about 55 %. Since later experiments with Na13'1 showed that about 45 % of the radioactivity remained absorbed to the insoluble polymeric materials, this experiment demonstrates that Polymer 3 is an effective precursor to (123I]MIBG. Similar results can also be expected with [1251]MIBG.

The process, according to the present invention, produces no-carrier-added [131 I]MIBG in 2t 90 % radiochemical yield and high chemical purity. Isolation and purification are simple, involving just filtration and absorption and desorption onto a C18 Sep-PakT""
cartridge. No-carrier-added material should avoid the potential pharmacological side effects accompanying the current method of production.

Although the above description refers to radioiodination of MIBG, such references are not intended to be limiting. The process and intermediate compound according to the present invention can be used for synthesis of any number radiolabelled haloaromatic compounds.

It will be appreciated that the above description relates to the preferred embodiment by way of example only. Many variations on the invention will be obvious to those knowledgeable in the field, and such obvious variations are within the scope of the lo invention as described and claimed, whether or not expressly described.

INDUSTRIAL APPLICABILITY

The process and precursor compounds, according to the present invention, is useful in the field of nuclear medicine for the production of radiopharmaceutical compounds.
-,-References 1) Wafelman, A.R., Konings, M.C.P., Hoefnagel, C.A., Maes, R.A.A. and Beijnen, J.H., Appl Radiat. Isot., 997 (1994) and references therein.

2) Vaidyanathan, G. and Zalutsky, M.R., Appl Radiat. lsot.,621 (1993).

3) Flanagan, R.J., Goel, A., Charleson, F.P. and Hunter, D.H., J. Label. Comp.
Radiopharm., 636 (1995).

Hunter, D.H., Goel, A. and Flanagan, R.J., "Process for the Preparation of Radiolaelled meta-Halobenzylguanidine", USA Patent No. 5,565,185.

4) Culbert, P.A., and Hunter, D.H., Polymer Supported Radiopharmaceuticals:
1231 and'3'1-1o Laabelled N-Isopropyl-4-lodoamphetamine, Reactive Polymers, 19, 247-253 (1993).

5) Gerigk, U., Gerlach, M., Neumann, W.P., Veiler, R. and Weintritt, V., Synthesis, 448 (1990).

6) R.A. Day, Jr.; A.L. Underwood, Quantitative Analysis Laboratory Manual (Prentice-Hall, Inc.), 2"d ed., p. 115-116, Englewood Cliffs, New Jersey, 1967.

7) Djuric, S., Venit, J., and Magnus, P., Tetrahedron Lett., 22, 1787-1790 (1981).

8) Shapiro, S.L., Parino, V.A., Rogow, E., Freedman, L., J. Am. Chem. Soc., 81, 3728 (1959).
AMENDED SHEET

Claims (23)

1. A process of preparing a radiolabelled haloaromatic compound (I) of the formula:

wherein, R2 is selected from an alkyl group, an aryl group, a hydrogen atom, a carbonyl group, a cyano group, an aminomethyl group, and a guanidinomethyl group;
*X is any suitable radiohalide;
said process comprising reacting a radiohalogen ion with an insoluble polymer compound (II) in the presence of a solvent and an oxidant, said polymer compound (II) having the formula:

wherein, R1 is an alkyl group;
and R2 is as defined above.
2. The process of claim 1, wherein R1 is a butyl group.
3. The process of claim 1, wherein *X is selected from 131I, 125I, and 123I.
4. The process of claim 1, wherein the solvent is an organic solvent.
5. The process of claim 4 where compound (I) has the formula:
wherein n is selected from 123, 125, and 131.
6. The process of claim 5, wherein n is 123.
7. The process of claim 5, wherein n is 131.
8. The process of claim 5, wherein n is 125.
9. The process of claim 5 wherein the polymer compound (II) has the formula:
10. An intermediate insoluble polymer compound of the repeating unit formula:
wherein, R1 is an alkyl group; and R2 selected from an alkyl group, an aryl group a hydrogen atom, a carbonyl group, a cyano group, an aminomethyl group, and a guanidinomethyl group.
11. The intermediate insoluble polymer compound of claim 10, wherein Ri is a butyl group.
12. The intermediate insoluble polymer compound of claim 11, having the formula:
13. The intermediate insoluble polymer compound of claim 11, having the formula:

14. A process of preparing an intermediate insoluble polymer compound of formula:
comprising reacting a compound of the formula:

with a 1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine compound of the structural formula:

15. A process for preparing an intermediate insoluble polymer compound of the formula:
comprising the steps of:
(a) reacting a first insoluble polymer compound of the formula:
with a 1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine compound of the structural formula:

to produce the compound having the formula:

(b) reacting a compound having the formula:

with toluene and NCNH2 to convert the ammonium group to a guanidinium group.
16. A process of preparing a compound of the formula:

comprising contacting a compound of the formula:
with iodine in an organic solvent.
17. The process of claim 16, wherein the organic solvent is selected from one or more of the group consisting of acetonitrile and chloroform.
18. A process of preparing a compound of the formula:
wherein n is selected from 123, 125, and 131;
said process comprising contacting a compound having the formula:
with a solution of Na"I and an oxidizing agent in the presence of a buffering agent; wherein n is as defined above.
19. The process of claim 18, wherein the oxidizing agent is selected from one or more of hydrogen peroxide and acetic acid.
20. The process of claim 18, wherein the buffering agent is KH2PO4.
21. The process of any one of claims 18-20, wherein n is 131.
22. The process of any one of claims 18-20, wherein n is 123.
23. The process of any one of claims 18-20, wherein n is 125.
CA002345710A 1997-10-02 1998-10-02 Preparation of radiolabelled haloaromatics via polymer-bound intermediates Expired - Lifetime CA2345710C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6088697P 1997-10-02 1997-10-02
US60/060,886 1997-10-02
PCT/CA1998/000933 WO1999018053A1 (en) 1997-10-02 1998-10-02 Preparation of radiolabelled haloaromatics via polymer-bound intermediates

Publications (2)

Publication Number Publication Date
CA2345710A1 CA2345710A1 (en) 1999-04-15
CA2345710C true CA2345710C (en) 2008-12-30

Family

ID=22032357

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002345710A Expired - Lifetime CA2345710C (en) 1997-10-02 1998-10-02 Preparation of radiolabelled haloaromatics via polymer-bound intermediates

Country Status (2)

Country Link
CA (1) CA2345710C (en)
WO (1) WO1999018053A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273601B2 (en) 2000-07-18 2007-09-25 The University Of Western Ontario Preparation of radiolabelled haloaromatics via polymer-bound intermediates
CA2709871C (en) 2001-03-02 2013-08-13 University Of Western Ontario Polymer precursors of radiolabeled compounds, and methods of making and using the same
AU2003301432B2 (en) * 2002-10-18 2008-11-06 Mcmaster University Methods for purifying radiolabelled compounds
GB0229686D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles
KR20060100200A (en) 2003-05-02 2006-09-20 더 유니버시티 오브 웨스턴 온타리오 Prosthetic groups useful in the synthesis of radiopharmaceutical compounds
EP1571150A1 (en) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Process for the preparation of tryptase inhibitors
GB0410448D0 (en) * 2004-05-11 2004-06-16 Hammersmith Imanet Ltd Purification methods
CN105622463B (en) 2006-12-26 2019-02-22 兰休斯医疗成像公司 For making the ligand of imaging cardiac innervation
RU2019142507A (en) 2010-05-11 2020-08-24 Лантеус Медикал Имэджинг, Инк. COMPOSITIONS, METHODS AND SYSTEMS FOR SYNTHESIS AND APPLICATION OF VISUALIZING AGENTS
EP2891657A1 (en) 2014-01-07 2015-07-08 Centre National de la Recherche Scientifique (CNRS) Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds
EP3131877B1 (en) * 2014-04-17 2023-07-19 Immunomet Therapeutics Inc. Biguanide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565185A (en) * 1994-07-20 1996-10-15 Merck Frosst Canada, Inc. Process for the preparation of radiolabeled meta-halobenzylguanidine

Also Published As

Publication number Publication date
CA2345710A1 (en) 1999-04-15
WO1999018053A1 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
Hunter et al. Polymer‐supported radiopharmaceuticals:[131I] MIBG and [123I] MIBG
CA2345710C (en) Preparation of radiolabelled haloaromatics via polymer-bound intermediates
Pirkle et al. Useful and easily prepared chiral stationary phases for the direct chromatographic separation of the enantiomers of a variety of derivatized amines, amino acids, alcohols, and related compounds
Gahan et al. Encapsulated metal ions: synthesis, structure, and spectra of nitrogen-sulfur ligand atom cages containing cobalt (III) and cobalt (II)
US20100274052A1 (en) Preparation of radiolabelled haloaromatics via polymer-bound intermediates
CN111675629A (en) Synthesis method and application of 4, 5-diphenyl imidazoline
Parker et al. Synthesis and characterization of stable rhenium (V) dioxo complexes with acyclic tetraamine ligands,[LReO2]+
US6461585B1 (en) Preparation of radiolabelled haloaromatics via polymer-bound intermediates
Thiverny et al. Inexpensive, multigram-scale preparation of an enantiopure cyclic nitrone via resolution at the hydroxylamine stage
Varzatskii et al. On a way to new types of the polyfunctional and polytopic systems based on cage metal complexes: cadmium-promoted nucleophilic substitution with low-active nucleophilic agents
CN101898970A (en) N-monosubstituted trans-1,2-diaminocyclohexane derivatives and preparation method thereof
CN109232586A (en) A kind of synthetic method of the more imidazole salts cage compounds of three-dimensional
Hörnfeldt et al. Synthesis of 11 C-Labelled Haloalkanonitriles and Examples of their Use in Some Alkylation Reactions
CN102260224B (en) Method for synthesizing 2-morpholone derivatives
CN108586187B (en) Carbon nanoring with anthracene unit inserted in cycloparaphenylene and synthetic method thereof
Baumeister et al. Central vs. peripheral Ag (i) coordination in NS 3-open chain and cage ligands
WO2017106340A1 (en) Isotopic fluorination and applications thereof
EP4140975A1 (en) Method for purifying organic compound and method for producing organic compound
JP5803136B2 (en) Amide-containing sulfide compound, and production method and use thereof
CN114957202B (en) Preparation method of DL-homocysteine thiolactone hydrochloride
VanArsdale et al. Nucleophilic addition to coordinated allyl ligands. Heteroatom nucleophiles with cationic molybdenum complexes
Stephan et al. Binding and extraction of pertechnetate and perrhenate by azacages
WO2023015138A1 (en) Lithium selective organogels
Ovian New Strategies for Stereocontrol of Highly Electrophilic Intermediates in Asymmetric Catalysis
CN115010739A (en) Method for synthesizing F-BPA

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20181002